2026 ICD-10-CM Diagnosis Code C96.6Unifocal Langerhans-cell histiocytosis

ICD-10-CM CodesC00–D49C81-C96C96

ICD-10-CM C96.6
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

C96.6 is a billable ICD-10-CM diagnosis code for unifocal Langerhans-cell histiocytosis. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Non-Hodgkin lymphoma.

Code Identity

ICD-10-CM Code
C96.6
Billable Status
Yes — Valid for Submission
Code Describes
Unifocal Langerhans-cell histiocytosis
Short Description
Unifocal Langerhans-cell histiocytosis
Same as the full description in the CMS dataset.
Parent Code
Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue

Code Classification

ChapterC00–D49Neoplasms
SectionC81-C96Malignant neoplasms of lymphoid, hematopoietic and related tissue
CategoryC96Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
This CodeC96.6Unifocal Langerhans-cell histiocytosis

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Eosinophilic granuloma
  • Eosinophilic granuloma of bone
  • Gastrointestinal eosinophilic granuloma
  • Langerhans cell histiocytosis
  • Langerhans cell histiocytosis - Hashimoto-Pritzker type
  • Langerhans cell histiocytosis of diaper area
  • Langerhans cell histiocytosis of lung
  • Langerhans cell histiocytosis of skin
  • Pulmonary eosinophilic granuloma
  • Pulmonary hypertension in Langerhans cell histiocytosis
  • Pulmonary hypertension in systemic disorder

Tabular List NotesGuidance

Coding notes and annotation back-references applicable to this code.

Inclusion Terms

  • Eosinophilic granuloma
  • Histiocytosis X, unifocal
  • Histiocytosis X NOS
  • Langerhans-cell histiocytosis NOS

Type 1 Excludes

  • multifocal and multisysemic disseminated Langerhans-cell histiocytosis C96.0
  • multifocal and unisystemic Langerhans-cell histiocytosis C96.5

Index to Diseases and InjuriesGuidance

Alphabetical index entries that point to this code.

External Cause of Injuries IndexGuidance

References for this code in the External Cause of Injuries Index.

    • Granuloma
      • bone
        • eosinophilic
    • Granuloma
      • bone
        • lung
    • Granuloma
      • eosinophilic
    • Granuloma
      • eosinophilic
        • bone
    • Granuloma
      • eosinophilic
        • lung
    • Granuloma
      • lung (infectious)
        • eosinophilic
    • Histiocytosis
      • Langerhans' cell NEC
    • Histiocytosis
      • Langerhans' cell NEC
        • unifocal (X)
    • Histiocytosis
      • mononuclear phagocytes NEC
        • Langerhans' cells
    • Histiocytosis
      • X NEC
    • Histiocytosis
      • X NEC
        • chronic
    • Histiocytosis
      • X NEC
        • unifocal

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR NEO058
Non-Hodgkin lymphoma
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Churg-Strauss Syndrome

    widespread necrotizing angiitis with granulomas. pulmonary involvement is frequent. asthma or other respiratory infection may precede evidence of vasculitis. eosinophilia and lung involvement differentiate this disease from polyarteritis nodosa.
  • Eosinophilic Granuloma

    the most benign and common form of langerhans-cell histiocytosis which involves localized nodular lesions predominantly of the bones but also of the gastric mucosa, small intestine, lungs, or skin, with infiltration by eosinophils.
  • Kimura Disease

    a chronic inflammatory disease characterized by benign enlargement of cervical lymph node and salivary glands with increased levels of immunoglobulin e. unlike angiolymphoid hyperplasia with eosinophilia it involves eosinophil infiltrates in lymph node and salivary glands and mostly found in asian males.
  • Polyarteritis Nodosa

    a form of necrotizing non-granulomatous inflammation occurring primarily in medium-sized arteries, often with microaneurysms. it is characterized by muscle, joint, and abdominal pain resulting from arterial infarction and scarring in affected organs. polyarteritis nodosa with lung involvement is called churg-strauss syndrome.
  • Eosinophils

    granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.

Patient EducationClinical

Langerhans cell histiocytosis

Langerhans cell histiocytosis is a disorder in which excess immune system cells called Langerhans cells build up in the body. Langerhans cells, which help regulate the immune system, are normally found throughout the body, especially in the skin, lymph nodes, spleen, lungs, liver, and bone marrow.

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert C96.6 to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
277.89 Metabolism disorder NEC
Approximate The match is approximate rather than exact.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About C96.6Overview

Is C96.6 a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report unifocal Langerhans-cell histiocytosis on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What is the ICD-9 equivalent of C96.6?

Under the General Equivalence Mappings, unifocal Langerhans-cell histiocytosis converts to ICD-9-CM 277.89 (metabolism disorder NEC). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.